Glyburide and Metformin Articles

Australian PBS adds 45 drugs, widens use for 28

8 August 2005

FDA clears Alpharma's Glucovance copy

11 July 2005

B-MS 1st-qtr 2005 income down 36%

9 May 2005

Australian PBS new Rx listings aimed at seniors

11 April 2005

Bristol-Myers Squibb reports 16% fall in 3rd-qtr earnings, though sales rise 1%

8 November 2004

B-MS reports 1st-qtr earnings jump 22%

3 May 2004

Pharmaceutical Resources to buy Kali

19 April 2004

IVAX first to file for generic Glucovance

1 March 2004

20% pharma sales rise boosts B-MS profits

9 February 2004

IVAX strikes Alpharma profit-sharing deal

8 December 2003

Sales near flat at Merck KGaA in third qtr, generics grow as pipeline is restructured

3 November 2003

UPDATE: B-MS beats forecasts in 2nd qtr

4 August 2003

Merck KGaA seeks stand-alone marketing in Japan

17 March 2003

Strong 4th-quarter operating results at Merck KGaA on flat sales

24 February 2003

Merck KGaA sales are hit by generics

29 July 2002

Double-digit growth rates elude most blockbuster firms, says Datmonitor

27 May 2002

Merck KGaA confident of surviving Glucophage declines

25 February 2002

Glucophage generics arrive on US market

4 February 2002

Update: Glucophage generic gets initial OK in USA

26 November 2001

Glucophage still driving Merck KGaA sales up to record heights

26 October 2001

Glucophage still driving Merck KGaA

27 July 2001

Merck KGaA operating profits up 17% as Glucophage products continue to rise

8 May 2001

Merck KGaA sets out plan to become number one in core businesses

20 February 2001

Modernizing Merck KGaA looking to long-term growth from pharma

8 November 2000

B-MS gets OK for Glucophage XR

18 October 2000

B-MS focuses on intense growth and reveals product pipeline

2 October 2000

B-MS gains FDA OK for Glucovance

4 August 2000

B-MS up on strong sales of Glucophage

24 July 2000

Merck KGaA to reveal late-stage news soon

20 June 2000

Showing 1-29 of 29 articles

Go to beginningPrevious
  • 1
NextGo to end